SummitTX Capital »

Travere Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.0M 112k 17.92

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Cisco Systems (CSCO)
MKS Instruments (MKSI)
NVIDIA Corporation (NVDA)
Cyberark Software SHS (CYBR)
PPL Corporation (PPL)
Meritage Homes Corporation (MTH)
Toll Brothers (TOL)
Teradyne (TER)
Applied Materials (AMAT)
Griffon Corporation (GFF)
Owens Corning (OC)

View all positions for SummitTX Capital

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics